In-depth, research-based writing on Boswellia serrata — mechanism, clinical trials, history, supplement selection, and safety. All claims sourced.
A thorough review of the RCT evidence — effect sizes, which extracts work best, comparison to NSAIDs, and the residual effects after stopping treatment that may be boswellia's most significant clinical advantage.
The precise molecular mechanism behind AKBA's anti-inflammatory action — and why it's distinctly different from how NSAIDs work.
From Egyptian temples and Silk Road caravans to 21st-century clinical trials — the full arc of boswellia's role in human civilization.
A label-reading guide: what standardization percentages mean, why AKBA content matters, bioavailability formulations, and red flags to avoid.
An honest assessment of boswellia's safety profile — clinical trial data, rare adverse events, drug interactions, and specific populations who should proceed with caution.
Articles on boswellia in studies of asthma, IBD, brain health, cancer research, and combination therapies are in development. Subscribe to be notified.
Get notified →Cookie Preferences
We use cookies to understand how this site is used and to improve your experience. You may accept or decline non-essential cookies at any time. Declining will not affect your ability to read content on this site.
California residents: declining opts you out of data sharing. See our Privacy Policy.